Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Cost of Revenue (2022 - 2024)

Moolec Science (MLECW) posted Cost of Revenue of $3.3 million for Q4 2024, up 115.1% sequentially from $1.5 million in Q3 2024, and up 16453.56% YoY from N/an in Q1 2024.

Moolec Science (MLECW) Cost of Revenue (2022 - 2024) Analysis & Trends

Moolec Science has reported Cost of Revenue for 3 years, with the latest figure at $3.3 million in Q4 2024.

  • Quarterly Cost of Revenue rose 16453.56% year-over-year to $3.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8.5 million (up 232.48% YoY) and the FY2024 annual result came in at $5.2 million, up 391.49% from the prior year.
  • Cost of Revenue improved to $3.3 million in Q4 2024 per MLECW's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $3.3 million in Q4 2024 and troughed at $5455.0 in Q1 2022.
  • A 3-year average of $923968.4 and a median of $507953.0 in 2022 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2023 and 2024: Cost of Revenue dropped 2.11% in 2023, then jumped 16453.56% in 2024.
  • Over 3 years, Cost of Revenue stood at $20473.0 in 2022, then slipped by 2.11% to $20040.0 in 2023, then surged by 16453.56% to $3.3 million in 2024.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $3.3 million, $1.5 million, and $1.6 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 93.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 174.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 298.26 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 387.98 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 67.21 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 3.32 Mn
Dec 31, 2024 3.32 Mn
Sep 30, 2024 1.54 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.59 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 2.02 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 20,040.00
Dec 31, 2023 20,040.00
Sep 30, 2023 1.52 Mn
Sep 30, 2023 1.52 Mn
Jun 30, 2023 994,199.00
Jun 30, 2023 994,199.00
Mar 31, 2023 14,364.00
Mar 31, 2023 14,364.00
Dec 31, 2022 20,473.00
Dec 31, 2022 20,473.00
Sep 30, 2022 19,318.00
Sep 30, 2022 19,318.00